- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1824-7288
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Secondary prophylaxis in rheumatic fever: is it time to change? ; volume:41 ; number:2 ; day:30 ; month:9 ; year:2015 ; pages:1 ; date:12.2015
The Italian journal of pediatrics ; 41, Heft 2 (30.9.2015), 1, 12.2015
- Urheber
-
Taddio, Andrea
Pirrone, A.
Pastore, Serena
Lepore, Loredana
Di Battista, Caterina
Simonini, Gabriele
Breda, Luciana
Cimaz, Rolando
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1824-7288-41-S2-A71
- URN
-
urn:nbn:de:101:1-2020100522495846777884
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Taddio, Andrea
- Pirrone, A.
- Pastore, Serena
- Lepore, Loredana
- Di Battista, Caterina
- Simonini, Gabriele
- Breda, Luciana
- Cimaz, Rolando
- SpringerLink (Online service)
Ähnliche Objekte (12)
Sharing success – understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease
Prophylaxis of Rheumatic Fever/Rheumatic Heart Disease–Penicillin or Azithromycin, Who Wins?
Efficacy of an incentive intervention on secondary prophylaxis for young people with rheumatic fever: a multiple baseline study
Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study
Enablers and barriers to secondary prophylaxis for rheumatic fever among Māori aged 14–21 in New Zealand: a framework method study
Pathology and therapy of rheumatic fever
Immunopathology of rheumatic fever and rheumatoid arthritis
Cardiac magnetic resonance in acute rheumatic fever
Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations
Rheumatic fever in a developed country – is it still relevant? A retrospective, 25 years follow-up
A community-based program to reduce acute rheumatic fever and rheumatic heart disease in northern Australia
Differentiation of post streptococcal reactive arthritis from acute rheumatic fever
Sharing success – understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease
Prophylaxis of Rheumatic Fever/Rheumatic Heart Disease–Penicillin or Azithromycin, Who Wins?
Efficacy of an incentive intervention on secondary prophylaxis for young people with rheumatic fever: a multiple baseline study
Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study
Enablers and barriers to secondary prophylaxis for rheumatic fever among Māori aged 14–21 in New Zealand: a framework method study
Pathology and therapy of rheumatic fever
Immunopathology of rheumatic fever and rheumatoid arthritis
Cardiac magnetic resonance in acute rheumatic fever
Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations
Rheumatic fever in a developed country – is it still relevant? A retrospective, 25 years follow-up
A community-based program to reduce acute rheumatic fever and rheumatic heart disease in northern Australia
Differentiation of post streptococcal reactive arthritis from acute rheumatic fever
Sharing success – understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease
Prophylaxis of Rheumatic Fever/Rheumatic Heart Disease–Penicillin or Azithromycin, Who Wins?
Efficacy of an incentive intervention on secondary prophylaxis for young people with rheumatic fever: a multiple baseline study
Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study
Enablers and barriers to secondary prophylaxis for rheumatic fever among Māori aged 14–21 in New Zealand: a framework method study
Pathology and therapy of rheumatic fever
Immunopathology of rheumatic fever and rheumatoid arthritis
Cardiac magnetic resonance in acute rheumatic fever
Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations
Rheumatic fever in a developed country – is it still relevant? A retrospective, 25 years follow-up
A community-based program to reduce acute rheumatic fever and rheumatic heart disease in northern Australia